Sources tell CNBC-TV18 that the US FDA has begun an inspection of Cipla's Goa facility. Goa is Cipla’s largest plant when it comes to the US FDA operations. It is around 20-25 percent of their total US sales in terms of filings etc. so there is always a little bit of uncertainty, which comes with any sort of US FDA inspection.